אירינוטקאן זריקות 20 מ"ג/מ"ל

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

IRINOTECAN (TRIHYDRATE) HYDROCHLORIDE 20 MG/ML

Dostupno od:

NOVAPHARMA LTD

ATC koda:

L01XX19

Farmaceutski oblik:

CONCENTRATE FOR SOLUTION FOR INFUSION

Administracija rute:

I.V

Proizveden od:

HOSPIRA AUSTRALIA PTY LTD

Terapijska grupa:

IRINOTECAN

Terapijske indikacije:

Irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer. For the treatment of patients with gastric cancer.

Datum autorizacije:

2012-11-01